BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20107732)

  • 1. Dyshidrosiform palmoplantar pemphigoid in a young man: response to dapsone.
    Lupi F; Masini C; Ruffelli M; Puddu P; Cianchini G
    Acta Derm Venereol; 2010; 90(1):80-1. PubMed ID: 20107732
    [No Abstract]   [Full Text] [Related]  

  • 2. Bullous pemphigoid masquerading as recurrent vesicular hand eczema.
    Veien NK
    Acta Derm Venereol; 2010; 90(1):4-5. PubMed ID: 20107717
    [No Abstract]   [Full Text] [Related]  

  • 3. Type XVII collagen ELISA indices significantly decreased after bullous pemphigoid remission.
    Kusajima E; Akiyama M; Sato M; Natsuga K; Shimizu H
    Int J Dermatol; 2011 Feb; 50(2):238-40. PubMed ID: 21244398
    [No Abstract]   [Full Text] [Related]  

  • 4. Case of atypical bullous pemphigoid with generalized pruritus and eczema as the prodrome for 10 years.
    Ikeda T; Okamoto K; Furukawa F
    J Dermatol; 2012 Aug; 39(8):720-1. PubMed ID: 22011062
    [No Abstract]   [Full Text] [Related]  

  • 5. [A severe course of bullous pemphigoid in a young man].
    Eigelshoven S; Bruch-Gerharz D; Enderlein E; Ruzicka T; Büchau AS; Hertl M; Reifenberger J; Schulte KW
    Hautarzt; 2006 Apr; 57(4):320-2. PubMed ID: 16523275
    [No Abstract]   [Full Text] [Related]  

  • 6. A case of pemphigoid vegetans with autoantibodies against both BP180 and BP230 antigens.
    Suda-Takayanagi T; Hara H; Ohyama B; Hashimoto T; Terui T
    J Am Acad Dermatol; 2011 Jan; 64(1):206-8. PubMed ID: 21167421
    [No Abstract]   [Full Text] [Related]  

  • 7. Peristomal bullous pemphigoid.
    Marzano AV; Vezzoli P; Colombo A; Serini SM; Crosti C; Berti E
    J Dermatol; 2010 Sep; 37(9):840-2. PubMed ID: 20883375
    [No Abstract]   [Full Text] [Related]  

  • 8. Association between effective dose of prednisolone, alone or in conjunction with other immunosuppressants, and titre of anti-bullous pemphigoid 180 antibody: a retrospective study of 42 cases.
    Miida H; Fujiwara H; Ito M
    Clin Exp Dermatol; 2011 Jul; 36(5):485-8. PubMed ID: 21392080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dyshidrosiform bullous pemphigoid].
    Mohr C; Duschet P; Bonsmann G; Luger TA; Gschnait F; Schwarz T
    Hautarzt; 1993 Dec; 44(12):785-8. PubMed ID: 8113043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bullous pemphigoid initially localized around the surgical wound of an arthroprothesis for coxarthrosis.
    Lo Schiavo A; Caccavale S; Alfano R; Gambardella A; Cozzi R
    Int J Dermatol; 2014 Apr; 53(4):e289-90. PubMed ID: 24261580
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoantibodies to basement membrane proteins BP180 and BP230 are commonly detected in normal subjects by immunoblotting.
    Desai N; Allen J; Ali I; Venning V; Wojnarowska F
    Australas J Dermatol; 2008 Aug; 49(3):137-41. PubMed ID: 18638220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case of bullous pemphigoid coexisting with anti-desmoglein autoantibodies.
    Tie D; Yoshida T; Chinuki Y; Da X; Ishikawa N; Morita E
    J Dermatol; 2017 Jul; 44(7):822-825. PubMed ID: 28342216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
    Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
    Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bullous pemphigoid of infancy - report and review of infantile and pediatric bullous pemphigoid.
    Ferreira BR; Vaz AS; Ramos L; Reis JP; Gonçalo M
    Dermatol Online J; 2017 Feb; 23(2):. PubMed ID: 28329498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lichen planus pemphigoides: detection of anti-BP 180 antibodies by ELISA and immunoblotting tests.
    Barnadas MA; Roé E; Dalmau J; Alomar A; Martínez L; Gelpí C
    J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1360-1. PubMed ID: 20337815
    [No Abstract]   [Full Text] [Related]  

  • 16. Paraneoplastic bullous pemphigoid: clinical disease activity correlated with enzyme-linked immunosorbent assay index for the NC16A domain of BP180.
    Song HJ; Han SH; Hong WK; Lee HS; Shin JH; Choi GS
    J Dermatol; 2009 Jan; 36(1):66-8. PubMed ID: 19207441
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of aggressive bullous pemphigoid associated with the defective functional variant of Fc gamma receptor IIb: implications for pathogenesis?
    Guilabert A; Lozano F; Iranzo P; Suárez-Casasús B; Martinez-De Pablo I; Julià M; Mascaró JM
    J Am Acad Dermatol; 2011 Nov; 65(5):1062-3. PubMed ID: 22000875
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study.
    Bernard P; Reguiai Z; Tancrède-Bohin E; Cordel N; Plantin P; Pauwels C; Vaillant L; Grange F; Richard-Lallemand MA; Sassolas B; Roujeau JC; Lok C; Picard-Dahan C; Chosidow O; Vitry F; Joly P
    Arch Dermatol; 2009 May; 145(5):537-42. PubMed ID: 19451497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyshidrosiform pemphigoid restricted to the soles.
    Hioki T; Shibata A; Makita S; Akiyama M
    Int J Dermatol; 2018 Jun; 57(6):742-743. PubMed ID: 29624662
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bullous pemphigoid: diagnostics and new therapeutic strategies].
    Hofmann SC; Bruckner-Tuderman L
    Dtsch Med Wochenschr; 2006 Feb; 131(8):389-92. PubMed ID: 16479471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.